Clinical TrialsSearch results
Number of results: 701
Other
- Phase II trial of endoscopic submucosal dissection to expand indication for early gastric cancer (JCOG0607)
- clinical T1 gastric cancer without submucosal invasion
- Japan Clinical Oncology Group (JCOG)
- 2007-06-08
Other
- Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (JCOG0706)
- unresectable locally advanced squamous cell carcinoma of the head and neck
- Japan Clinical Oncology Group (JCOG)
- 2008-07-28
Other
- Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)
- esophageal neoplasm
- Japan Clinical Oncology Group (JCOG)
- 2009-02-27
Other
- Rituximab + standard CHOP (R S-CHOP) vs Rituximab + bi-weekly CHOP (R Bi-CHOP) RCT(phase II/III) low-grade B-cell lymphoma at advanced stage (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)
- Untreated CD20-positive low-grade B-cell lymphoma at advanced stage
- Japan Clinical Oncology Group(JCOG)
- 2005-07-30
Other
- Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)
- Stage III colorectal cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12
Other
- Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)
- Non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-04
Other
- Randomized phase III study of 5-FU continuous infusion (5FUci) versus MTX+5-FU sequential therapy (MF) in gastric cancer with peritoneal metastasis (JCOG0106-MF, MF/5FU)
- gastric cancer with peritoneal metastasis
- Japan Clinical Oncology Group(JCOG)
- 2005-09-07
Other
- Randomized phase III study of 5-FU continuous infusion (5-FUci) versus CPT-11 plus CDDP (CP) versus S-1 alone (S-1) in advanced gastric cancer (JCOG9912)
- advanced or recurrent gastric cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-16
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04
Other
- Randomized phase II study of gemcitabine and S-1 combination therapy versus S-1 in advanced biliary tract cancer. (JCOG 0805)
- biliary tract neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2009-02-04